| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |